Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis

MLA

Elliott D. Crouser, et al. “Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis.” Chest, vol. 159, no. 5, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....01c082ed44ab03040e7cc9a1aabfd19a&authtype=sso&custid=ns315887.

APA

Elliott D. Crouser, Amy Kerrigan, Marc A. Judson, Daniel A. Culver, Tan Ding, Abena Green, Ahmed Sesay, K. Abel, Gregory D. Ayers, Gordon R. Bernard, Wonder P. Drake, Robert P. Baughman, & W. Ennis James. (2020). Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis. Chest, 159(5).

Chicago

Elliott D. Crouser, Amy Kerrigan, Marc A. Judson, Daniel A. Culver, Tan Ding, Abena Green, Ahmed Sesay, et al. 2020. “Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis.” Chest 159 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....01c082ed44ab03040e7cc9a1aabfd19a&authtype=sso&custid=ns315887.